Stericycle (NASDAQ:SRCL) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Stericycle (NASDAQ:SRCL) in a report issued on Tuesday. The firm set a “hold” rating on the business services provider’s stock.

SRCL has been the topic of several other research reports. Keefe, Bruyette & Woods lifted their price objective on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $62.00 price target (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Finally, Truist Financial raised their price objective on shares of Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a report on Tuesday, June 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Stericycle has an average rating of “Hold” and a consensus price target of $74.00.

Stericycle Trading Up 0.0 %

Shares of SRCL stock opened at $61.70 on Tuesday. The firm has a market capitalization of $5.73 billion, a P/E ratio of -280.45, a price-to-earnings-growth ratio of 3.37 and a beta of 1.11. Stericycle has a 1 year low of $37.78 and a 1 year high of $61.77. The firm’s fifty day simple moving average is $59.13 and its 200 day simple moving average is $54.67. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.04. The company had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. As a group, sell-side analysts predict that Stericycle will post 2.29 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Clearstead Trust LLC acquired a new stake in shares of Stericycle during the 1st quarter worth about $25,000. Principal Securities Inc. bought a new position in shares of Stericycle in the fourth quarter valued at approximately $41,000. GAMMA Investing LLC raised its stake in shares of Stericycle by 170.9% in the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 516 shares during the last quarter. TFO Wealth Partners LLC boosted its holdings in shares of Stericycle by 22,325.0% in the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after acquiring an additional 893 shares in the last quarter. Finally, Headlands Technologies LLC bought a new stake in Stericycle during the 1st quarter worth approximately $44,000. 98.82% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.